Search

Your search keyword '"Flebbe, Dillon R."' showing total 23 results

Search Constraints

Start Over You searched for: Author "Flebbe, Dillon R." Remove constraint Author: "Flebbe, Dillon R."
23 results on '"Flebbe, Dillon R."'

Search Results

1. Mucosal adenovirus vaccine boosting elicits IgA and durably prevents XBB.1.16 infection in nonhuman primates

2. Variant-proof high affinity ACE2 antagonist limits SARS-CoV-2 replication in upper and lower airways

3. mRNA-1273 protects against SARS-CoV-2 beta infection in nonhuman primates

4. Durable immunity to SARS-CoV-2 in both lower and upper airways achieved with a gorilla adenovirus (GRAd) S-2P vaccine in non-human primates

5. Mucosal Adenoviral-vectored Vaccine Boosting Durably Prevents XBB.1.16 Infection in Nonhuman Primates

6. RBD-based high affinity ACE2 antagonist limits SARS-CoV-2 replication in upper and lower airways

7. mRNA-1273 or mRNA-Omicron boost in vaccinated macaques elicits similar B cell expansion, neutralizing responses, and protection from Omicron

8. mRNA-1273 or mRNA-Omicron boost in vaccinated macaques elicits comparable B cell expansion, neutralizing antibodies and protection against Omicron

9. Protection against SARS-CoV-2 Beta variant in mRNA-1273 vaccine–boosted nonhuman primates

10. Immune correlates of protection by mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primates

11. Protective antibodies elicited by SARS-CoV-2 spike protein vaccination are boosted in the lung after challenge in nonhuman primates

12. Protection against SARS-CoV-2 Beta Variant in mRNA-1273 Boosted Nonhuman Primates

13. Evaluation of mRNA-1273 against SARS-CoV-2 B.1.351 Infection in Nonhuman Primates

14. Immune Correlates of Protection by mRNA-1273 Immunization against SARS-CoV-2 Infection in Nonhuman Primates

15. Vaccination with SARS-CoV-2 Spike Protein and AS03 Adjuvant Induces Rapid Anamnestic Antibodies in the Lung and Protects Against Virus Challenge in Nonhuman Primates

16. Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates

17. Durable immunity to SARS-CoV-2 in both lower and upper airways achieved with a gorilla adenovirus (GRAd) S-2P vaccine in non-human primates.

18. Mucosal Adenoviral-vectored Vaccine Boosting Durably Prevents XBB.1.16 Infection in Nonhuman Primates.

19. RBD-based high affinity ACE2 antagonist limits SARS-CoV-2 replication in upper and lower airways.

20. Protection against SARS-CoV-2 Beta Variant in mRNA-1273 Boosted Nonhuman Primates.

21. Evaluation of mRNA-1273 against SARS-CoV-2 B.1.351 Infection in Nonhuman Primates.

22. Immune Correlates of Protection by mRNA-1273 Immunization against SARS-CoV-2 Infection in Nonhuman Primates.

23. Vaccination with SARS-CoV-2 Spike Protein and AS03 Adjuvant Induces Rapid Anamnestic Antibodies in the Lung and Protects Against Virus Challenge in Nonhuman Primates.

Catalog

Books, media, physical & digital resources